Plöderl, Martin

Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression.

Hengartner, M. P., & Plöderl, M. (2022) · BMJ Evidence-Based Medicine

Treatment of Major DepressionHealth Systems, Economic Evaluations, Quality of Life

Cited by 114

Suicidality and Associated Risk Factors Among Lesbian, Gay, and Bisexual Compared to Heterosexual Austrian Adults

Plöderl, M., & Fartacek, R. (2005) · Suicide and Life-Threatening Behavior

LGBTQ Health, Identity, and PolicySuicide and Self-Harm Studies

Cited by 80

Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA

Hengartner, M. P., & Plöderl, M. (2021) · Therapeutic Advances in Psychopharmacology

Treatment of Major DepressionStatistical Methods in Clinical Trials

Cited by 23

False Beliefs in Academic Psychiatry: The Case of Antidepressant Drugs

Hengartner, M. P., & Plöderl, M. (2018) · Ethical Human Psychology and Psychiatry

Treatment of Major DepressionPain Management and Placebo Effect

Cited by 10

Dynamic association between suicidal ambivalence and suicide risk among individuals with a history of suicide attempts.

Fartacek, C., Fartacek, R., Schiepek, G. K., Sturm, J., Aichhorn, W., & Plöderl, M. (2024) · Suicide and Life-Threatening Behavior

Suicide and Self-Harm StudiesMental Health Research Topics

Cited by 6

Esketamine Nasal Spray versus Quetiapine for Resistant Depression

Horowitz, M. A., Plöderl, M., & Naudet, F. (2024) · New England Journal of Medicine

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 1